In-Home EEG Options During COVID-19
Long-Duration Monitored VEEG at Home Protects Patients, Provides Timely Diagnosis
To limit the spread of COVID-19 and create capacity, elective procedures are being canceled across the nation and many Epilepsy Monitoring Units and Neurodiagnostic Labs are limiting or suspending services. This has caused patients to delay diagnostic care, while in turn reducing the income for physician practices and hospitals. However, there are alternatives to provide hospital-quality EEG studies in a patient's home.
The American Clinical Neurophysiology Society (ACNS) has outlined a set of ACNS COVID-19 Resources, including a section on managing requests for neurodiagnostic testing. Among the alternatives to elective EEG monitoring and EMU admissions, are the consideration of long-duration monitored video EEG when medically appropriate in a patient's home.
With healthcare providers around the globe looking for telemedicine
alternatives in response to the COVID-19 outbreak, neurologists have
a tested solution available to protect their seizure care patients.
To help create access to in-home EEG for patients, Lifelines Neuro is joining forces with our EEG Service Provider partners to create awareness of alternatives to hospital-based EEG. As pioneers in-home and ambulatory EEG, our Trackit EEG amplifiers and systems are used in roughly 50 percent of all U.S. in-home EEG studies.
Whether you are interested in performing your own EEG studies or looking for a turnkey EEG solution, we can help ensure patients get the timely neurodiagnostic care needed.
Lifelines Neuro's Rendr Platform cloud software provides physicians access to review studies 24/7/365, anytime, anywhere on multiple platforms and devices.
Learn more and receive a complimentary assessment to review options that best meet your needs.